Impaired CD95 expression predisposes for recurrence in curatively resected colon carcinoma: clinical evidence for immunoselection and CD95L mediated control of minimal residual disease

Background: Loss of CD95 expression in tumour cells occurs frequently in colon carcinoma and may be associated with disease progression. On the other hand, neo-expression of CD95L in tumour cells may contribute to immune evasion. Aims: We aimed at further exploring the functional role and prognostic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sträter, J, Hinz, U, Hasel, C, Bhanot, U, Mechtersheimer, G, Lehnert, T, Möller, P
Formato: Artigo
Lenguaje:Inglês
Publicado: Copyright 2005 by Gut 2005
Materias:
Colorectal Cancer
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC1774512/
https://ncbi.nlm.nih.gov/pubmed/15831912
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2004.052696
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares